Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matter

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Immuno-Oncology Technology|January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanomaD König, B Kasenda, M Sandholzer, et al.
Hepatology Communications|April 16, 2021
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family MembersMairene Coto-Llerena, Nadia Tosti, Stephanie Taha-Mehlitz, et al.
Communications Medicine|May 23, 2022
Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case reportCaner Ercan, Mairene Coto-Llerena, John Gallon, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Coordinated immune-epithelial dynamics in the nasal epithelium protect against respiratory virus infectionYao Yu Yeo, Hsin-Yi Chen, Bokai Zhu, et al.
Biochemical and Biophysical Research Communications|July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effectsAnne Dropmann, Sophie Alex, Katharina Schorn, et al.
Gastroenterology|December 14, 2023
Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in CholangiocarcinomaMonika Lewinska, Ekaterina Zhuravleva, Letizia Satriano, et al.
Gut|June 10, 2024
PARP-1 selectively impairs <i>KRAS</i>-driven phenotypic and molecular features in intrahepatic cholangiocarcinomaFriederike L Keggenhoff, Darko Castven, Diana Becker, et al.
Science Immunology|June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancerClara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Hepatology Communications|February 8, 2022
miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed LiverCristina Quintavalle, Nathalie Meyer-Schaller, Stephanie Roessler, et al.
Journal of Hepatology|June 8, 2023
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristicsSarp Uzun, Carl P Zinner, Amke C Beenen, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Immuno-Oncology Technology|January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanomaD König, B Kasenda, M Sandholzer, et al.
Hepatology Communications|April 16, 2021
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family MembersMairene Coto-Llerena, Nadia Tosti, Stephanie Taha-Mehlitz, et al.
Communications Medicine|May 23, 2022
Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case reportCaner Ercan, Mairene Coto-Llerena, John Gallon, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Coordinated immune-epithelial dynamics in the nasal epithelium protect against respiratory virus infectionYao Yu Yeo, Hsin-Yi Chen, Bokai Zhu, et al.
Biochemical and Biophysical Research Communications|July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effectsAnne Dropmann, Sophie Alex, Katharina Schorn, et al.
Gastroenterology|December 14, 2023
Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in CholangiocarcinomaMonika Lewinska, Ekaterina Zhuravleva, Letizia Satriano, et al.
Gut|June 10, 2024
PARP-1 selectively impairs <i>KRAS</i>-driven phenotypic and molecular features in intrahepatic cholangiocarcinomaFriederike L Keggenhoff, Darko Castven, Diana Becker, et al.
Science Immunology|June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancerClara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Hepatology Communications|February 8, 2022
miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed LiverCristina Quintavalle, Nathalie Meyer-Schaller, Stephanie Roessler, et al.
Journal of Hepatology|June 8, 2023
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristicsSarp Uzun, Carl P Zinner, Amke C Beenen, et al.
Pageof 11